André Choulika
Founder bij CELLECTIS S.A.
Vermogen: 3 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van André Choulika
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 48 | |
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris.
30
| Foundation/Endowment | Investment Trusts/Mutual Funds | 30 |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.
27
| Non-Profit Organization | Miscellaneous Commercial Services | 27 |
Université Pierre et Marie Curie
26
| Extinct | Other Consumer Services | 26 |
Calyxt, Inc.
 Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Calyxt, Inc. is technology company. engages in delivering plant-based solutions. Its products include high oleic soybean oil, high fiber wheat, high oleic soybean meal, and low lignin alfalfa. The company was founded by Daniel F. Voytas and André Choulika on January 8, 2010 and is headquartered in Roseville, MN.
22
| Extinct | Miscellaneous Commercial Services | 22 |
Cellectis, Inc.
 Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The private company is based in New York, NY. André Choulika has been the CEO of the company since 2014.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met André Choulika via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
LFB Biotechnologies SASU
 LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Masters Business Admin Doctorate Degree Undergraduate Degree | |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| SCYNEXIS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| Babson College | College/University | Undergraduate Degree Masters Business Admin | |
| University of Toronto | College/University | Graduate Degree | |
Elaia Partners SAS
 Elaia Partners SAS Investment ManagersFinance Elaia Partners SAS (Elaia) is an independent French private equity boutique which was founded in 2002. Named after the Greek word for olive tree, the symbol of resilience, longevity and prosperity, Elaia focuses on software technology companies. The firm is headquartered in Paris and manages Elaia Ventures, a French FCPR fund backed by financial institutions, industrial investors and family offices. | Investment Managers | Private Equity Investor Private Equity Investor | |
| London School of Economics & Political Science | College/University | Corporate Officer/Principal Graduate Degree | |
| THERADIAG | Medical Specialties | Chairman Chief Executive Officer | |
Ariana Pharmaceuticals SA
 Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NEOVACS | Pharmaceuticals: Major | Founder Director/Board Member | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| ESSEC Business School | College/University | Chief Executive Officer Undergraduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| École Normale Supérieure | College/University | Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Graduate Degree | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | President Director/Board Member General Counsel Chief Executive Officer | |
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| CARMAT | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Director/Board Member Director/Board Member | |
InGen Biosciences SA
 InGen Biosciences SA Medical SpecialtiesHealth Technology InGen Biosciences SA is engaged in the development of in-vitro diagnostic products for use in medical biology laboratories. The company was founded in 1993 and it is headquartered in Chilly-Mazarin, France. | Medical Specialties | Director/Board Member Chief Executive Officer | |
Hemarina SA
 Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Biotechnology | Chairman Chief Executive Officer | |
Novartis Pharma SAS
 Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France. | Pharmaceuticals: Major | Chief Operating Officer Chief Executive Officer | |
Messier Maris & Associés SCA
 Messier Maris & Associés SCA Investment ManagersFinance Messier Maris & Associés SCA provides financial consulting and investment advisory services. The company was founded by Jean-Marie Messier and Erik Maris in 2010 and is headquartered in Paris, France. | Investment Managers | Founder Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| REVO BIOLOGICS INC | Biotechnology | Director/Board Member Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Undergraduate Degree | |
| LYSOGENE | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
Shango NV
 Shango NV Financial ConglomeratesFinance Shango NV is a well-established cannabis brand that offers a full range of award-winning products, including flower, extracts, concentrates, and cannabis-infused edibles. The private company is based in Nevada, USA, and has subsidiaries in other states. The Belgian company has operations in multiple locations and has full-service recreational and medical cannabis dispensaries in various cities. Shango is building several facilities for cultivation, extraction, and production. The company also operates a state-of-the-art cannabis distribution center in southern Nevada. Shango is committed to cannabis education and advocates for the safe and responsible use of cannabis products. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Hougou Développement SA
 Hougou Développement SA Financial ConglomeratesFinance Hougou Développement SA is an investment holding private company based in Ixelles, Belgium. The Belgian company's main function is to hold investments in other companies. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Kotys SA | Director/Board Member Director/Board Member | ||
EnobraQ SAS
 EnobraQ SAS Chemicals: Major DiversifiedProcess Industries EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
| CORETECH 5 | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
Hougou Finance SA
 Hougou Finance SA Financial ConglomeratesFinance Hougou Finance SA is an investment holding Belgian company founded in 2016. The private company is based in Ixelles, Belgium. | Financial Conglomerates | Chairman Director/Board Member | |
| IDORSIA LTD | Pharmaceuticals: Major | Chairman Chairman | |
MicroPEP Technologies SAS
 MicroPEP Technologies SAS Miscellaneous Commercial ServicesCommercial Services MicroPEP Technologies SAS engages in the development of biomimetic peptides that manage plant genetics. The company was founded by Thomas Laurent on April 15, 2016 and is headquartered in Toulouse, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The private company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chairman Chairman | |
Ribogenics, Inc.
 Ribogenics, Inc. BiotechnologyHealth Technology Ribogenics, Inc. is a biotechnology company. The private company is based in Philadelphia, PA. The CEO of the company is Yves Joseph Ribeill. | Biotechnology | Chief Executive Officer Director/Board Member | |
Inserm-Transfert SA
 Inserm-Transfert SA Miscellaneous Commercial ServicesCommercial Services Inserm-Transfert SA engages in the managements of economic and societal value creation and the transfer of knowledge. It operates in the human health innovation sector. The company was founded in 2000 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
| Université PSL | College/University | Director/Board Member Director/Board Member | |
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer Director/Board Member |
Statistieken
Internationaal
| Frankrijk | 32 |
| Verenigde Staten | 11 |
| België | 4 |
| Zwitserland | 3 |
| Canada | 2 |
Sectoraal
| Health Technology | 23 |
| Consumer Services | 15 |
| Finance | 7 |
| Commercial Services | 6 |
| Process Industries | 3 |
Operationeel
| Director/Board Member | 301 |
| Corporate Officer/Principal | 125 |
| Chairman | 75 |
| Chief Executive Officer | 64 |
| Independent Dir/Board Member | 50 |
Sterkste connecties
| Insiders | |
|---|---|
| Pierre Bastid | 29 |
| Jean-Pierre Garnier | 28 |
| Franck Lescure | 28 |
| Mathieu Simon | 22 |
| Laurent Arthaud | 21 |
| Jean-Marie Messier | 18 |
| David Sourdive | 16 |
| Jean-Yves Nothias | 16 |
| Marc Le Bozec | 16 |
| Michel Finance | 15 |
| Jonathan Fassberg | 15 |
| Stéphanie Fougou | 14 |
| Cédric Moreau | 14 |
| Elsy Boglioli Hofman | 14 |
| Rainer Boehm | 12 |
- Beurs
- Insiders
- André Choulika
- Bedrijfsconnecties
